Instead of targeting excessively high uric acid levels as existing gout drugs do, the new strategy aims to reduce overall inflammation. The drug goes after a specific inflammatory molecule called interleukin-1.
from WebMD Health https://ift.tt/2pim1x2
0 comments:
Post a Comment